S

STLN

STLN

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
50%Neutral
Buy/Sell Ratio2% buys
BearishBullish
STLN Live QuoteReal-time
$3.18
$3.65(-53.44%)1M
Day Range$3.16 – $3.47
Open$3.25
Previous Close$3.20
Volume2.83M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$326.37M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.28
Price to Book0.8
Dividend Yield0.65%
Beta (Volatility)0.41
IndustryMEDICAL CARE FACILITIES
52-Week RangeCurrent: $3.18 (18%)
Low: $2.32High: $7.13
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$9.25-93.8% upside

Insider Buys

2

$255K

Insider Sales

2

$13.32M

Total Volume

$13.58M

4 transactions

Net Activity

$13.07M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 98% of total transaction value.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
C
1

Chernett Jorey

10%

2 buys1 sells

$11.63M total

H
2

Hively Brad

Dir

0 buys1 sells

$1.95M total

Trading History
STLN insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 6, 2026

2 weeks ago

Chernett Jorey

10%

10% Owner
Sell2.85M$3.99$11.38M

Nov 9, 2026

1 weeks ago

Chernett Jorey

10%

10% Owner
Buy48.3K$3.65$176K

Aug 21, 2026

3 months ago

Hively Brad

Dir

Director
Sell298.9K$6.51$1.95M

Aug 14, 2026

3 months ago

Chernett Jorey

10%

10% Owner
Buy12.0K$6.54$78K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
STLN Buy Conviction2%
Industry Rank#133 of 569
Volume Contribution0.1%
Total Industry Activity$16.53B

STLN has an insider buy conviction of 2%, compared to the Unknown sector buy average of 6%. STLN ranks #133 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for STLN

Over the last 90 days, corporate insiders at STLN (STLN) engaged in a total of 4 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 2 were sales. The total volume of insider trading reached $13.58M.

The net insider activity for STLN shows a net selling bias of $13.07M. This activity represents a 2% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Chernett Jorey (10%), who traded 2.85M shares valued at $11.38M on Nov 6, 2026.

Live Market News & Developments
Aggregated real-time headlines for STLN (STLN)
6 updates

The Oncology Institute, Inc. (STLN) Stock Price, News, Quote & History

Yahoo! Finance Canada105d ago

symbol__ Stock Quote Price and Forecast

CNN103d ago

Starling Oncology (STLN) Stock Forum and Discussion

Moomoo36d ago

STLN - Starling Oncology Inc Stock Price and Quote

Finviz107d ago

Starling Oncology Inc (STLN) Stock Price, Quote, News & History

Benzinga107d ago

What is the current Price Target and Forecast for Starling Oncology, Inc. (STLN)

Zacks Investment Research103d ago

FAQs About STLN Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for STLN.

Based on SEC Form 4 disclosures, the Insider Confidence Score for STLN is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 2 purchases and 2 sales by company executives over the last 90 days.

The CEO Conviction Index for STLN is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.